Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.4600
-0.0050 (-1.08%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $12.63 million as of October 15, 2026. It is the 40,184th most valuable company in the world and the 5,482nd biggest in the United States. Its market cap has decreased by 42.86% in one year.
Market Cap
12.63M
Enterprise Value
2.80M
1-Year Change
-42.86%
Global Rank
Country Rank
#5,482 United States
Category
ChartMarket Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $12.63M, a decrease of -58.87%. That is a compound annual growth rate of -9.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 12.63M | -21.56% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 13.90M |
| Pasithea Therapeutics | 13.90M |
| Tvardi Therapeutics | 13.88M |
| Lipocine | 13.77M |
| Allarity Therapeutics | 13.74M |
| Vyome Holdings | 13.48M |
| Cerenome | 13.43M |
| Palatin Technologies | 12.76M |